Featured Stories

Myocardial Scarring Persists in Patients with COVID-19 Vaccine-Associated Myocarditis

The Longitudinal Study Includes More Than 400 Children, Adolescents, and Young Adults Across 38 Hospitals

The latest findings from the longitudinal multicenter study on COVID-19 vaccine-associated myocarditis (C-VAM), called MACiV (Myocarditis After COVID Vaccination), in 333 children, adolescents, and young adults led by Supriya Jain, M.D., FSCMR, FACC, FAAP, associate professor of pediatrics, radiology, and of public health, showed that while 82 percent of the patients in the study had evidence of myocardial injury on cardiac MRI at initial presentation, 60 percent of those patients had persistence of myocardial scarring on follow up examinations. The study, which is in pre-print in The Lancet, is supported by a Broad Agency Agreement of $1,997,031 by the Food and Drug Administration.

Stories

Ask the big questions. Be part of important conversations. Touro sponsors the Forum on Life, Culture & Society (FOLCS) which uses the arts as a catalyst for conversation and as a tool to re-examine the status quo, so we can develop ideas and together help build a better world. Join us!

Visit FOLCS

Touro Events

May 5May 5, 2024 11:00am – 5:00pm ETCommunicating STEM Through Digital Literacy & Art

Graduate School of Education, NYSCAS - New York School of Career and Applied Studies

May 6May 6, 2024 10:00am ETTouroCOM Harlem M.S. Class of 2024 Commencement

Touro College of Osteopathic Medicine - Harlem

May 9May 9, 2024 12:00pm – 4:00pm ETTouro Research Day: Resilience and Persistence

Touro

Around Touro

    Media Contacts

    Ellie Schlam

    Executive Director of Communications and Marketing

    (646) 565-6420

    Barbara Franklin

    Director of Communications

    (646) 565-6531